Jupiter Topco LLC Acquires New Stake in Kenvue Inc. $KVUE

Key Points

• Jupiter Topco LLC acquired 397,673 Kenvue shares in the second quarter, valued at approximately $7.6 million. Other institutions also established or expanded positions, with institutional investors owning 97.64% of the stock.
• Kenvue reported quarterly revenue of $3.96 billion, up 3% year over year, but missed analyst expectations on both revenue and EPS, posting $0.31 per share versus the $0.32 consensus.
• The company paid a quarterly dividend of $0.21 per share, equivalent to an annualized yield of about 4.4%. Analysts maintain a consensus “Hold” rating with an average price target of $19.27, close to the stock’s $19.15 price.

Jupiter Topco LLC bought a new position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 397,673 shares of the company's stock, valued at approximately $7,600,000.

Other large investors have also bought and sold shares of the company. Kintayl Capital LP bought a new stake in shares of Kenvue in the 2nd quarter valued at about $7,094,000. Hsbc Holdings PLC raised its position in shares of Kenvue by 34.3% during the second quarter. Hsbc Holdings PLC now owns 7,544,394 shares of the company's stock worth $143,893,000 after acquiring an additional 1,926,217 shares during the last quarter. Ancora Advisors LLC bought a new position in shares of Kenvue during the second quarter worth about $313,000. Canada Pension Plan Investment Board acquired a new position in shares of Kenvue in the second quarter worth approximately $74,895,000. Finally, Kapitalo Investimentos Ltda acquired a new position in shares of Kenvue in the second quarter worth approximately $1,108,000. 97.64% of the stock is owned by institutional investors.

Kenvue Price Performance

Shares of KVUE opened at $19.15 on Monday. The firm has a market cap of $36.78 billion, a PE ratio of 22.01, a price-to-earnings-growth ratio of 1.37 and a beta of 0.47. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $20.82. The business's 50 day moving average price is $19.16 and its two-hundred day moving average price is $18.25. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.71 and a current ratio of 1.01.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The company had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.97 billion. During the same period last year, the business earned $0.29 EPS. The business's quarterly revenue was up 3.0% compared to the same quarter last year. On average, equities analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th were issued a $0.21 dividend. The ex-dividend date was Wednesday, August 12th. This is a positive change from Kenvue's previous quarterly dividend of $0.21. This represents a $0.84 dividend on an annualized basis and a yield of 4.4%. Kenvue's dividend payout ratio is 96.55%.

Analysts Set New Price Targets

KVUE has been the subject of a number of recent analyst reports. Zacks Research downgraded shares of Kenvue from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 7th. Barclays boosted their price target on shares of Kenvue from $18.00 to $19.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 21st. Wall Street Zen lowered shares of Kenvue from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Weiss Ratings upgraded shares of Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a research report on Monday, June 15th. Finally, UBS Group lowered their target price on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating for the company in a research note on Tuesday, August 11th. Three investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $19.27.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source